NewAmsterdam Pharma Company N.V. Stock Deutsche Boerse AG
Equities
KH6
NL00150012L7
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.25 EUR | +4.29% |
|
+15.13% | +78.57% |
Sales 2024 * | 8.64M 9.26M | Sales 2025 * | 6.31M 6.77M | Capitalization | 1.66B 1.78B |
---|---|---|---|---|---|
Net income 2024 * | -210M -225M | Net income 2025 * | -139M -149M | EV / Sales 2024 * | 193 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 264 x |
P/E ratio 2024 * |
-7.91
x | P/E ratio 2025 * |
-12.3
x | Employees | 40 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.29% |
Latest transcript on NewAmsterdam Pharma Company N.V.
1 day | +4.29% | ||
1 week | +15.13% | ||
Current month | +8.02% | ||
1 month | +6.06% | ||
3 months | -12.50% | ||
6 months | +62.04% | ||
Current year | +78.57% |
![Extreme 15.3](/images/extremecours_fleche.png)
![Extreme 15.1](/images/extremecours_fleche.png)
![Extreme 9.6](/images/extremecours_fleche.png)
![Extreme 5.4](/images/extremecours_fleche.png)
![Extreme 5.4](/images/extremecours_fleche.png)
![Extreme 5.4](/images/extremecours_fleche.png)
![Extreme 5.4](/images/extremecours_fleche.png)
Date | Price | Change |
---|---|---|
24-06-27 | 17.5 | 0.00% |
24-06-26 | 17.5 | +0.57% |
24-06-25 | 17.4 | +9.43% |
24-06-24 | 15.9 | +3.92% |
24-06-21 | 15.3 | +0.66% |
Delayed Quote Deutsche Boerse AG, June 27, 2024 at 09:29 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.28% | 122B | |
+21.59% | 115B | |
+20.84% | 26.64B | |
-22.38% | 19.91B | |
-17.08% | 16.32B | |
-44.74% | 15.52B | |
-19.46% | 15.49B | |
+59.87% | 14.83B | |
+2.37% | 13.67B |
- Stock Market
- Equities
- NAMS Stock
- KH6 Stock